Back to top

Mirum Advances New Drug Candidate With Fresh Phase 1 Study Update

Mirum Pharmaceuticals ($MIRM) announced an update on their ongoing clinical study. Mirum Pharmaceuticals, Inc. is running a Phase 1 trial called “A...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Mirum Pharmaceuticals, Inc. (MIRM)